10 High Growth Healthcare Stocks to Invest in Now

4. BioNTech SE (NASDAQ:BNTX)

Revenue Growth: 83.94% 

BioNTech SE (NASDAQ:BNTX) is a German biotechnology company that specializes in developing and manufacturing immunotherapies for patient-specific approaches. At its core, the company focuses on creating messenger RNA (mRNA) therapeutics and vaccines to address serious diseases such as cancer and infectious diseases.

The company stands out as one of the high-growth healthcare stocks to consider for investment in the current market. BioNTech SE (NASDAQ: BNTX) reported Q3 2024 financial results with revenues of €1,244.8 million, up from €895.3 million in Q3 2023. Net profit rose to €198.1 million, from €160.6 million last year, and diluted earnings per share increased to €0.81 ($0.89) from €0.66. The revenue boost was driven by the approval and successful launch of COVID-19 vaccines for the 2024/2025 season. The company anticipates full-year 2024 revenues to be at the lower end of the €2.5-3.1 billion guidance range.

As of Q3 2024, 30 hedge fund holders held shares in the company, as tracked by the Insider Monkey database. The largest stakeholder in the stock was Balyasny Asset Management with shares worth $73.6 million. Street analysts hold a consensus Strong Buy rating on the stock with an average 12-month price target of $137.87, with a high forecast of $171.00 and a low of $121.00. This represents a potential 21.87% upside from its current price of $113.13.